-+ 0.00%
-+ 0.00%
-+ 0.00%

TD Cowen Initiates Coverage On RAPT Therapeutics with Buy Rating

Benzinga·12/18/2025 13:06:48
Listen to the news
TD Cowen analyst Yaron Werber initiates coverage on RAPT Therapeutics (NASDAQ:RAPT) with a Buy rating.